bumetanide has been researched along with Critical Illness in 7 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bumetanide can induce generalized musculoskeletal pain when administered as a continuous infusion, an effect that may be underrecognized." | 8.02 | Pain Associated With Continuous Intravenous Infusion of Bumetanide: A Case Series. ( Brighton, DD; Herges, JR; Herges, LB; Jentzer, JC; Ou, NN, 2021) |
| "This prospective, open-label, clinical trial was conducted to describe the pharmacology of bumetanide in pediatric patients with edema." | 5.08 | Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients. ( Kearns, GL; Letzig, L; Marshall, JD; Wells, TG, 1998) |
| "Bumetanide can induce generalized musculoskeletal pain when administered as a continuous infusion, an effect that may be underrecognized." | 4.02 | Pain Associated With Continuous Intravenous Infusion of Bumetanide: A Case Series. ( Brighton, DD; Herges, JR; Herges, LB; Jentzer, JC; Ou, NN, 2021) |
| " Half-life and mean residence time decreased markedly in the first month of life (p < 0." | 2.68 | Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants. ( Blumer, JL; Myers, CM; Sullivan, JE; Witte, MK; Yamashita, TS, 1996) |
| " Data were evaluated by standard noncompartmental pharmacokinetic techniques." | 2.68 | Pharmacokinetics of bumetanide in critically ill infants. ( Blumer, JL; Myers, CM; Sullivan, JE; Witte, MK; Yamashita, TS, 1996) |
| " Time course patterns for urine flow rate and electrolyte excretion were similar for all dosage groups." | 2.68 | Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants. ( Blumer, JL; Myers, CM; Sullivan, JE; Witte, MK; Yamashita, TS, 1996) |
| " Dosing practices were described by rate (μg/kg/hr), duration (days), and previous diuretic use." | 1.42 | Bumetanide continuous infusions in critically ill pediatric patients. ( Briceno-Medina, M; Chhim, RF; Figueroa, M; McCallister, KM; Rayburn, M; Shelton, CM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Herges, LB | 1 |
| Jentzer, JC | 1 |
| Brighton, DD | 1 |
| Herges, JR | 1 |
| Ou, NN | 1 |
| McCallister, KM | 1 |
| Chhim, RF | 1 |
| Briceno-Medina, M | 1 |
| Shelton, CM | 1 |
| Figueroa, M | 1 |
| Rayburn, M | 1 |
| Bulkley, CF | 1 |
| Johnson, PN | 1 |
| Henry, E | 1 |
| Harrison, D | 1 |
| Lewis, TV | 1 |
| Miller, JL | 1 |
| Sullivan, JE | 3 |
| Witte, MK | 3 |
| Yamashita, TS | 3 |
| Myers, CM | 3 |
| Blumer, JL | 3 |
| Marshall, JD | 1 |
| Wells, TG | 1 |
| Letzig, L | 1 |
| Kearns, GL | 1 |
5 trials available for bumetanide and Critical Illness
| Article | Year |
|---|---|
Bumetanide continuous-infusion dosing in critically ill pediatric patients.
Topics: Bumetanide; Child, Preschool; Critical Illness; Drug Administration Schedule; Female; Humans; Infant | 2012 |
Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.
Topics: Aging; Bumetanide; Critical Illness; Diuretics; Female; Heart Diseases; Humans; Infant; Infant, Newb | 1996 |
Pharmacokinetics of bumetanide in critically ill infants.
Topics: Area Under Curve; Bumetanide; Chromatography, High Pressure Liquid; Critical Illness; Diuretics; Fem | 1996 |
Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants.
Topics: Bumetanide; Critical Illness; Diuretics; Dose-Response Relationship, Drug; Electrolytes; Female; Hum | 1996 |
Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients.
Topics: Adult; Alkalosis; Area Under Curve; Bumetanide; Child; Child, Preschool; Chlorides; Creatine; Critic | 1998 |
2 other studies available for bumetanide and Critical Illness
| Article | Year |
|---|---|
Pain Associated With Continuous Intravenous Infusion of Bumetanide: A Case Series.
Topics: Bumetanide; Critical Illness; Humans; Incidence; Infusions, Intravenous; Pain | 2021 |
Bumetanide continuous infusions in critically ill pediatric patients.
Topics: Adolescent; Bumetanide; Child; Child, Preschool; Critical Care; Critical Illness; Diuretics; Dose-Re | 2015 |